2. Academic Validation
  3. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy

The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy

  • Nature. 2014 Jun 19;510(7505):370-5. doi: 10.1038/nature13418.
Baris Bingol 1,  Joy S Tea 1,  Lilian Phu 2,  Mike Reichelt 3,  Corey E Bakalarski 4,  Qinghua Song 5,  Oded Foreman 3,  Donald S Kirkpatrick 2,  Morgan Sheng 6
Affiliations

Affiliations

  • 1 1] Department of Neuroscience, Genentech, Inc., South San Francisco, California 94080, USA [2].
  • 2 Department of Protein Chemistry, Genentech, Inc., South San Francisco, California 94080, USA.
  • 3 Department of Pathology, Genentech, Inc., South San Francisco, California 94080, USA.
  • 4 Department of Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, California 94080, USA.
  • 5 Department of Non-Clinical Biostatistics, Genentech, Inc., South San Francisco, California 94080, USA.
  • 6 Department of Neuroscience, Genentech, Inc., South San Francisco, California 94080, USA.
PMID: 24896179 DOI: 10.1038/nature13418
Abstract

Cells maintain healthy mitochondria by degrading damaged mitochondria through mitophagy; defective Mitophagy is linked to Parkinson's disease. Here we report that USP30, a Deubiquitinase localized to mitochondria, antagonizes Mitophagy driven by the ubiquitin Ligase parkin (also known as PARK2) and protein kinase PINK1, which are encoded by two genes associated with Parkinson's disease. Parkin ubiquitinates and tags damaged mitochondria for clearance. Overexpression of USP30 removes ubiquitin attached by parkin onto damaged mitochondria and blocks parkin's ability to drive Mitophagy, whereas reducing USP30 activity enhances mitochondrial degradation in neurons. Global ubiquitination site profiling identified multiple mitochondrial substrates oppositely regulated by parkin and USP30. Knockdown of USP30 rescues the defective Mitophagy caused by pathogenic mutations in parkin and improves mitochondrial integrity in parkin- or PINK1-deficient flies. Knockdown of USP30 in dopaminergic neurons protects flies against paraquat toxicity in vivo, ameliorating defects in dopamine levels, motor function and organismal survival. Thus USP30 inhibition is potentially beneficial for Parkinson's disease by promoting mitochondrial clearance and quality control.

Figures